Teladoc Health Inc [TDOC] Investment Appeal on the Rise

Teladoc Health Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER DIVITA CHARLES III unloaded Company’s shares for reported $0.13 million on Sep 11 ’25. In the deal valued at $7.59 per share,16,787 shares were sold. As a result of this transaction, DIVITA CHARLES III now holds 179,014 shares worth roughly $1.41 million.

Then, DIVITA CHARLES III bought 16,787 shares, generating $127,435 in total proceeds.

Before that, Rodrigues Fernando M. sold 4,149 shares. Teladoc Health Inc shares valued at $31,491 were divested by the President of BetterHelp at a price of $7.59 per share. As a result of the transaction, Rodrigues Fernando M. now holds 0 shares, worth roughly $0.0.

Mizuho initiated its Teladoc Health Inc [TDOC] rating to a Neutral in a research note published on July 25, 2025; the price target was $10. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in mid November with a ‘”a Buy”‘ rating. Jefferies also remained covering TDOC and reiterated its “Hold” recommendation on September 17, 2024. Cantor Fitzgerald started covering the stock on February 29, 2024. It rated TDOC as “an Overweight”.

Price Performance Review of TDOC

On Tuesday, Teladoc Health Inc [NYSE:TDOC] saw its stock jump 2.61% to $7.87. Over the last five days, the stock has gained 0.90%. Teladoc Health Inc shares have risen nearly 3.28% since the year began. Nevertheless, the stocks have fallen -13.42% over the past one year.

How much short interest is there in Teladoc Health Inc?

A steep rise in short interest was recorded in Teladoc Health Inc stocks on 2025-08-29, dropping by -0.99 million shares to a total of 23.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 24.01 million shares. There was a decline of -4.28%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on February 26, 2024 when Leerink Partners began covering the stock and recommended ‘”a Market perform”‘ rating along with a $17 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.